Nanotherapeutics
Nanotherapeutics has been studied in 2 papers since 2024: none in people yet, 2 reviews; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 19, 2026: “Integrating emerging preservation strategies in cardiac transplantation: From nanotherapeutic frontiers to clinical translation”.
2 papers study it1 findingUpdated
1 new paper in 30 daysSee all 2 papers on nanotherapeutics
- Funder: National Institute of Diabetes and Digestive and Kidney Diseases
What did studies of nanotherapeutics find?
1Studies of nanotherapeutics measured one outcome, neural disorders.
Neural disorders
downin reviews1
1 study
Neural disorders
downin reviews1
Nanotherapeutics decrease neural disorders.
“neuroglia-directed nanotherapeutic approaches to mitigate the burden of various neural disorders.”
Review
Neuroglia targeting nano-therapeutic approaches to rescue aging and neurodegenerating brain
International journal of pharmaceutics
Funding
1 grant since 2018National Institute of Diabetes and Digestive and Kidney Diseases$2.4M